Partners in Financial Planning Invests $213,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Partners in Financial Planning purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 421 shares of the healthcare conglomerate’s stock, valued at approximately $213,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. O Shaughnessy Asset Management LLC raised its position in shares of UnitedHealth Group by 6.1% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 119,351 shares of the healthcare conglomerate’s stock worth $60,375,000 after acquiring an additional 6,813 shares in the last quarter. Inkwell Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $2,158,000. Brandywine Global Investment Management LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $99,043,000. Joseph Group Capital Management boosted its stake in UnitedHealth Group by 15.6% in the fourth quarter. Joseph Group Capital Management now owns 7,408 shares of the healthcare conglomerate’s stock valued at $3,747,000 after acquiring an additional 998 shares in the last quarter. Finally, RWA Wealth Partners LLC increased its position in shares of UnitedHealth Group by 1.0% during the fourth quarter. RWA Wealth Partners LLC now owns 60,031 shares of the healthcare conglomerate’s stock worth $30,368,000 after purchasing an additional 565 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have commented on UNH. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday, January 10th. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 0.0 %

UNH opened at $515.47 on Monday. The company has a market cap of $471.51 billion, a price-to-earnings ratio of 33.26, a PEG ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business’s fifty day moving average is $508.81 and its two-hundred day moving average is $543.92.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.63%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.